HK$19.27 ($2.46)

-0.13 (-0.67%)

Weekly Expected Move ±7.6%

HK$16 HK$18 HK$19 HK$21 HK$22

HKSE · Healthcare · Medical - Care Facilities · Tech Score Buy · Power 57 · HK$4.8B mcap · 203M float · 0.178% daily turnover

Revenue

$2.6B +19.9% ▲

5Y CAGR: +12.9%

Gross Profit

$1.2B +21.8% ▲

5Y CAGR: +10.9%

Operating Income

$322M +10.5% ▲

5Y CAGR: +9.2%

Net Income

$228M +5.9% ▲

5Y CAGR: +10.2%

EPS (Diluted)

$0.99 +5.3% ▲

5Y CAGR: +10.2%

EBITDA

$427M -33.7% ▼

5Y CAGR: -0.2%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$1.5B	$1.8B	$1.6B	$2.1B	$2.6B
YoY Growth	+7.0%	+18.5%	-8.2%	+31.2%	+19.9%
Cost of Revenue	$803M	$947M	$918M	$1.2B	$1.4B
Gross Profit	$700M	$834M	$718M	$977M	$1.2B
Gross Margin	46.6%	46.8%	43.9%	45.6%	46.3%
R&D Expenses	$13M	$18M	$31M	$34M	$36M
SG&A Expenses	$117M	$149M	$171M	$167M	$850M
Operating Expenses	$487M	$556M	$566M	$686M	$868M
Operating Income	$213M	$278M	$152M	$291M	$322M
Operating Margin	14.2%	15.6%	9.3%	13.6%	12.5%
Interest Expense	$26M	$24M	$25M	$25M	$28M
Income Before Tax	$189M	$255M	$130M	$288M	$318M
Tax Expense	$36M	$47M	$20M	$58M	$65M
Net Income	$151M	$193M	$103M	$216M	$228M
Net Margin	10.0%	10.9%	6.3%	10.1%	8.9%
EPS (Diluted)	$0.65	$0.84	$0.45	$0.94	$0.99
EBITDA	$474M	$555M	$452M	$645M	$427M
Shares Outstanding	231M	231M	231M	230M	230M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$901M	$1.0B	$1.1B	$1.1B	$1.4B	$1.5B	$1.5B	$1.9B
Cost of Revenue	$497M	$559M	$609M	$603M	$779M	$739M	$789M	$915M
Gross Profit	$404M	$478M	$499M	$534M	$656M	$720M	$752M	$967M
Gross Margin	44.8%	46.1%	45.0%	47.0%	45.7%	49.3%	48.8%	51.4%
R&D Expenses	$16M	$17M	$17M	$16M	$20M	$21M	$21M	$21M
SG&A Expenses	$288M	$333M	$364M	$371M	$479M	$488M	$505M	$628M
Operating Expenses	$289M	$323M	$363M	$371M	$497M	$496M	$517M	$632M
Operating Income	$108M	$146M	$136M	$163M	$159M	$224M	$235M	$335M
Operating Margin	12.0%	14.1%	12.3%	14.3%	11.1%	15.4%	15.3%	17.8%
Interest Expense	$28M	$28M	-$3M	$0	$1M	$3M	$16M	$0
Income Before Tax	$104M	$153M	$135M	$160M	$157M	$221M	$229M	$320M
Tax Expense	$14M	$32M	$26M	$34M	$31M	$50M	$60M	$81M
Net Income	$88M	$112M	$104M	$115M	$113M	$156M	$162M	$222M
Net Margin	9.8%	10.8%	9.4%	10.1%	7.9%	10.7%	10.5%	11.8%
EPS (Diluted)	$0.44	$0.48	$0.45	$0.50	$0.49	$0.68	$0.69	$0.91
EBITDA	$163M	$202M	$184M	$213M	$214M	$283M	$316M	$563M
Shares Outstanding	200M	229M	231M	230M	230M	231M	233M	245M

2373.HK HKSE